Tag:
BioClinica
Latest Headlines
Latest Headlines
UPDATED: BioClinica chief touts Microsoft ties in Q1 report
BioClinica ($BIOC) capitalized on the compatibility of its clinical trials software with Microsoft ($MSFT) technology and boosted revenue and income during the first quarter that ended March 31, the company said last week.
BioClinica and NextDocs partner on eClinical software
BioClinica ($BIOC) and venture-backed NextDocs revealed their efforts to integrate each company's software for pharmaceutical companies.
BioClinica sheds light on 2012 outlook, eyes ePRO tech for trials
BioClinica CEO Mark Weinstein aims to sail to a year of growth in 2012, charting a course for the company last week while announcing fourth-quarter 2011 results. And the provider of clinical trials...
Clinical IT outfit upsizes as Big Pharma customers downsize
BioClinica ( $BIOC ) has plans to hire 55 people this year as the provider of clinical trials software and imaging services scales up its operation, which serves companies--such as Pfizer ( $PFE )--that...
BioClinica profit slides in 3Q
BioClinica ( $BIOC ), a provider of clinical trials software and imaging core lab services, saw its profits fall in the third quarter. The company's GAAP net income fell from $808,000 in the third...
BioClinica continues revenue growth streak
Make that 6 consecutive quarters of year-over-year revenue growth. BioClinica ($BIOC), a provider of clinical trials software and services, says today that its service revenue and profits jumped in
Exclusive CEO Q&A: BioClinica chief Mark Weinstein on firm's eClinical makeover
BioClinica CEO Mark Weinstein
A little over three years into transforming his company into a provider of diverse clinical trials software and services, BioClinica CEO Mark Weinstein says
CRO partner choices show analytics trend
Two contract researchers are taking different collaborative approaches to separate from the CRO pack. One has chosen alignment with an adaptive trials specialist; the other, with a trial automation
GSK opts for BioClinica IVR system across trials
GlaxoSmithKline ( $GSK ) has selected BioClinica's Trident interactive web response system for use across Phase I through IV trials. The drug giant wants internal staff to be able to set up and manage
BioClinica EDC deal should help settle investor Nicusa
E-clinical solutions provider BioClinica , not skipping a beat since a recent investor tantrum , has signed a three-year deal for enterprise-wide EDC technology and data management services with a top
